M02 logo

M02 (M02)

Market Closed
16 Oct, 08:00 PM
XFRA XFRA
€
0. 03
+0
+3.8168%
€
10.98M Market Cap
- P/E Ratio
- Div Yield
1,000 Volume
- Eps
€ 0.03
Previous Close
Add Transaction
Day Range
0.03 0.03
Year Range
0.02 0.04
Want to track M02 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

M02 closed today higher at €0.03, an increase of 3.8168% from yesterday's close, completing a monthly increase of 2.2556% or €0. Over the past 12 months, M02 stock lost -32%.
M02 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

M02 Chart

People also search for

W55
Nutun Limited
€ 0.04
0%
0MU
MailUp S.p.A.
€ 1.72
-5.2486%
UM3
UMC Electronics Co., Ltd.
€ 1.07
-0.9259%
B7Z
Arribatec Group ASA
€ 0.5
-4.1985%
Q58
Secure Inc.
€ 6.9
+0.7299%

M02 (M02) FAQ

What is the stock price today?

The current price is €0.03.

On which exchange is it traded?

M02 is listed on XFRA.

What is its stock symbol?

The ticker symbol is M02.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 10.98M.

Has M02 ever had a stock split?

No, there has never been a stock split.

M02 Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
- CEO
XFRA Exchange
- ISIN
Sweden Country
7 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

iZafe Group AB (publ) is a pioneering life-science company specialized in the research, development, and marketing of digital medical solutions and services aimed at enhancing drug management safety for individuals at home. Originally established as MediRätt AB (publ), the company underwent a name change to iZafe Group AB (publ) in May 2019, signaling its evolution and broadened ambition within the digital healthcare sector. Since its inception in 2008, iZafe Group has been committed to addressing the challenges of medication management through innovative technologies. Based in Stockholm, Sweden, the company extends its reach to consumers and care providers across Sweden, the Nordic countries, and the international market, catering to both the public and private sectors.

Products and Services

  • Dosell - an automated drug dispenser designed to simplify and secure the process of medication intake for individuals. The device is equipped to handle dose bags, facilitating easier and more independent medication management for users. Dosell ensures that medications are taken at the correct times by providing reminders and alerts for missed doses. This product highlights iZafe Group's commitment to leveraging technology to improve health outcomes and support independent living.

Contact Information

Address: David Bagares Gata 3
Phone: 46 8 21 11 21